Logo
  • Search
  • Subscribe
  • Login
  • News
  • Business
  • Opinion
  • Archive
  • About DT
  • Contact
  • Search
  • Subscribe
  • Login

Gavi applauds MSF’s effort to break Pfizer vaccine monopoly in India

News December 29, 2017

Anuradha Gupta, Deputy CEO of the vaccine alliance Gavi, says Médecins Sans Frontières (MSF)’s legal challenge of a Pfizer patent in India could, if successful, contribute to making the pharmaceutical market more “healthy.” Revoking the patent would break Pfizer’s monopoly on pneumonia vaccine, opening the way for cheaper generic copies to enter the market.

Anuradha gupta Gavi.jpg

The rest of the content is only available for subscribers.

Log in or subscribe

Tags:

AMC vaccine deal Global health
  • Home
  • Archive
  • 2017
  • DT 10 / 2017
  • Gavi applauds MSF’s effort to break Pfizer vaccine monopoly in India

Development Today AS
Box 140
1371 Asker
Norway
Tel: +47 66902660
E-mail: devtoday@devtoday.no

  • News
  • Business
  • Opinion
  • Archive
  • About DT
  • Privacy and Cookie policy
  • Contact
  • Log in
  • Subscribe

Design and development: Snapper Net Solutions